Kay D. Davis, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3725 Lake Trail Dr, Kenner, LA 70065 Phone: 504-616-7710 Fax: 504-885-3225 |
Alexandria Spizale Wright, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4704 Janice Ave, Kenner, LA 70065 Phone: 504-417-6767 Fax: 504-455-0983 |
Alexa Rachal Accardo, MCD, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4704 Janice Ave, Kenner, LA 70065 Phone: 504-417-0838 |
Amy C Froeba, M.C.D., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4305 Indiana Ave, Kenner, LA 70065 Phone: 504-616-3388 |
Kaycee Marie Caron, MCD, CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 3801 Loyola Dr, Kenner, LA 70065 Phone: 504-230-0929 |
Amanda Stewart, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 65 Coronado Ave, Kenner, LA 70065 Phone: 504-717-7613 |
Mrs. Brittani Holland Gonzalez, MCD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4704 Janice Ave, Kenner, LA 70065 Phone: 504-444-2819 |
Ms. Meher H. Banajee, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 27 Madera Ct, Kenner, LA 70065 Phone: 504-450-6264 |
Jessica Lynn Stevens, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3837 Loyola Dr, Kenner, LA 70065 Phone: 504-699-7401 |
Caroline Rhoades Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4121 Medoc Dr, Kenner, LA 70065 Phone: 504-464-5662 |
Mrs. Michaela Accardo, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5412 David Dr, Kenner, LA 70065 Phone: 504-455-0983 |
Miss Megan Alane Prados, M.C.D., SLP-CFY Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4704 Janice Ave, Kenner, LA 70065 Phone: 504-455-0983 |
Mrs. Amy Carrubba D'alfonso, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4101 Saint James Dr, Kenner, LA 70065 Phone: 504-468-9482 |
Denise Marie Solomon, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2200 Veterans Memorial Blvd, Suite 103, Kenner, LA 70062 Phone: 504-461-4266 Fax: 504-461-9976 |
Accardo Speech, Language And Learning, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4704 Janice Ave, Kenner, LA 70065 Phone: 504-417-6767 |
Emily Watkins Toups, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1600 Joe Yenni Blvd, Kenner, LA 70065 Phone: 504-467-1000 |
News Archive
Celtic Pharmaceutical Holdings L.P. ("Celtic Pharma") today announced the formation of a strategic partnership between Ipsen and Inspiration Biopharmaceuticals ("Inspiration") to create a world leading hemophilia franchise, an important milestone for the Celtic Pharma portfolio.
The Commission on Cancer (CoC) of the American College of Surgeons (ACS) has granted its 2012 Outstanding Achievement Award to a select group of 79 accredited cancer programs throughout the United States.
Scientists at Oregon Health & Science University's Casey Eye Institute and Baylor College of Medicine's Cullen Eye Institute published findings from a two-year Phase I clinical trial in the journal Ophthalmology, which showed that children had the greatest benefit from gene therapy for treatment of Leber congenital amaurosis (LCA) or severe early childhood onset retinal degeneration (SECORD).
Most patients taking opioids for low back pain or other pain syndromes are prescribed low-to moderate doses, but a substantial number are given higher doses. Although there is no consensus on an absolute limit because tolerance varies over time among individual patients, what is known, however, is higher does are associated with elevated risks for side effects, addiction, overdoses and death.
A new review of the latest evidence on sugar-sweetened beverages (SSBs)- which includes 30 new studies published between 2013 and 2015 (and none of them industry sponsored) - concludes that SSB consumption is associated with overweight and obesity, and that countries that have not already done so should take action to reduce the consumption of the so-called 'empty calories' that these drinks contain.
› Verified 3 days ago